BC patients are divided into four major molecular subtypes: luminal A (ER+, PR±, HER2−), luminal B (ER+, PR±, HER2±), HER2+ (ER−, PR−, HER2+), and TNBC (ER−, PR−, HER2−) [56]. Here, ERBB2 is linked to breast cancer.